CD8+CD103+ tumor-infiltrating lymphocytes are tumor-specific tissue-resident memory T cells and a prognostic factor for survival in lung cancer patients

The Journal of Immunology : Official Journal of the American Association of Immunologists
Fayçal DjenidiFathia Mami-Chouaib

Abstract

We had previously demonstrated the role of CD103 integrin on lung tumor-infiltrating lymphocyte (TIL) clones in promoting specific TCR-mediated epithelial tumor cell cytotoxicity. However, the contribution of CD103 on intratumoral T cell distribution and functions and the prognosis significance of TIL subpopulations in non-small cell lung carcinoma (NSCLC) have thus far not been systematically addressed. In this study, we show that an enhanced CD103(+) TIL subset correlates with improved early stage NSCLC patient survival and increased intraepithelial lymphocyte infiltration. Moreover, our results indicate that CD8(+)CD103(+) TIL, freshly isolated from NSCLC specimens, display transcriptomic and phenotypic signatures characteristic of tissue-resident memory T cells and frequently express PD-1 and Tim-3 checkpoint receptors. This TIL subset also displays increased activation-induced cell death and mediates specific cytolytic activity toward autologous tumor cells upon blockade of the PD-1-PD-L1 interaction. These findings emphasize the role of CD8(+)CD103(+) tissue-resident memory T cells in promoting intratumoral CTL responses and support the rationale for using anti-PD-1 blocking Ab to reverse tumor-induced T cell exhaustion i...Continue Reading

References

Oct 1, 1990·European Journal of Immunology·P J Kilshaw, S J Murant
Oct 9, 2002·The Journal of Experimental Medicine·Ye FengGregg A Hadley
Nov 26, 2002·Immunological Reviews·Giovanna BossiGillian M Griffiths
May 20, 2003·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·E QuinnR Ward
Nov 5, 2003·The Journal of Experimental Medicine·Santos MañesCarlos Martínez-A
Apr 27, 2005·Proceedings of the National Academy of Sciences of the United States of America·Nadia AnikeevaYuri Sykulev
Sep 24, 2005·The Journal of Immunology : Official Journal of the American Association of Immunologists·Tonia WoodberryChristian Brander
Oct 12, 2005·The Journal of Experimental Medicine·Oliver AnnackerFiona Powrie
Feb 4, 2006·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sun-Sang J SungSteven R Beaty
Aug 19, 2006·Nature Medicine·Lydie TrautmannRafick-Pierre Sekaly
Sep 27, 2006·The Journal of Experimental Medicine·Gordon J FreemanArlene H Sharpe
Oct 3, 2007·Cancer Immunology, Immunotherapy : CII·Selma UgurelJürgen C Becker
Feb 26, 2008·Expert Opinion on Biological Therapy·Karin JöhrerRichard Greil
Sep 24, 2008·Proceedings of the National Academy of Sciences of the United States of America·Shawn D BlackburnE John Wherry
Jul 30, 2009·Cancer Research·Katarzyna FranciszkiewiczFathia Mami-Chouaib
Nov 27, 2009·Nature·Thomas Gebhardt, Francis R Carbone
Feb 17, 2010·The Journal of Experimental Medicine·David MasopustRafi Ahmed
Sep 8, 2010·The Journal of Experimental Medicine·Kaori SakuishiAna C Anderson
Oct 7, 2010·Proceedings of the National Academy of Sciences of the United States of America·Linda M WakimMichael J Bevan
Dec 14, 2011·Annual Review of Immunology·Jason G Cyster, Susan R Schwab
Mar 23, 2012·Nature Reviews. Cancer·Drew M Pardoll
Apr 18, 2012·Proceedings of the National Academy of Sciences of the United States of America·Laura K MackayThomas Gebhardt
Jun 5, 2012·The New England Journal of Medicine·Suzanne L TopalianMario Sznol
Aug 28, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Linda M WakimMichael J Bevan
Nov 8, 2012·Mucosal Immunology·L S Cauley, L Lefrançois
Oct 29, 2013·Nature Immunology·Laura K MackayThomas Gebhardt
Nov 6, 2013·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·John R WebbBrad H Nelson
Jan 15, 2014·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Stéphane ChampiatJean-Charles Soria
Jan 31, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·M'barka MokraniFathia Mami-Chouaib
Feb 13, 2014·Immunological Reviews·Damian L TurnerDonna L Farber
Mar 29, 2014·The Journal of Clinical Investigation·Alena GrosSteven A Rosenberg

❮ Previous
Next ❯

Citations

Feb 26, 2016·Frontiers in Immunology·Francesca Di Rosa, Thomas Gebhardt
Jan 7, 2016·Nature Medicine·Christopher A KlebanoffNicholas P Restifo
Sep 18, 2015·Journal of the American Society of Nephrology : JASN·Qi CaoDavid C H Harris
Jun 18, 2016·Journal of Immunology Research·John Reiser, Arnob Banerjee
Mar 25, 2017·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Karla A Ruiz-Ceja, Yolanda I Chirino
Apr 17, 2017·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Daniela MassiMario Mandalà
May 20, 2017·British Journal of Cancer·Alexandria P CogdillJennifer A Wargo
Feb 5, 2016·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Roy M BremnesTom Dønnem
Jun 20, 2017·Nature Immunology·Anusha-Preethi GanesanChristian H Ottensmeier
Jan 5, 2017·Nihon Rinshō Men'eki Gakkai kaishi = Japanese journal of clinical immunology·Rei Watanabe
Jul 20, 2017·Nature Immunology·Derk AmsenRene A W van Lier
Jul 20, 2016·European Journal of Immunology·Enrico LugliDomenico Mavilio
Jan 10, 2018·The Journal of Immunology : Official Journal of the American Association of Immunologists·Briana G Nixon, Ming O Li
Mar 17, 2018·Médecine sciences : M/S·Clémence GranierÉric Tartour
Mar 8, 2018·Journal for Immunotherapy of Cancer·Keith E SteeleTobias Wiestler
Apr 18, 2018·Immunological Reviews·James L ReadingSergio A Quezada
Feb 7, 2018·Frontiers in Immunology·Aurélie DurgeauFathia Mami-Chouaib
May 20, 2018·Nature Immunology·Derk AmsenRene A W van Lier
Aug 30, 2018·Veterinary and Comparative Oncology·Sita S WithersRobert B Rebhun
Nov 6, 2018·Journal of Leukocyte Biology·Dounia ChraaAbdallah Badou
Dec 7, 2017·Nature·J Justin MilnerAnanda W Goldrath
Jun 30, 2015·Nature Medicine·Chang Ook Park, Thomas S Kupper
Feb 7, 2019·Annual Review of Immunology·David Masopust, Andrew G Soerens
Jun 25, 2019·Expert Opinion on Therapeutic Targets·Hendrik Ungefroren
Jul 30, 2019·Immunological Reviews·Smita S Chandran, Christopher A Klebanoff
Sep 4, 2019·Nature Communications·Ainhoa ArinaRalph R Weichselbaum
Aug 28, 2019·Nature Communications·Nicole MarquardtJakob Michaëlsson
Sep 28, 2017·Immunology and Cell Biology·Simone L Park, Laura K Mackay
May 7, 2020·Cancers·Jian GaoAnja Ehrhardt

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cadherins and Catenins

Cadherins (named for "calcium-dependent adhesion") are a type of cell adhesion molecule (CAM) that is important in the formation of adherens junctions to bind cells with each other. Catenins are a family of proteins found in complexes with cadherin cell adhesion molecules of animal cells: alpha-catenin can bind to β-catenin and can also bind actin. β-catenin binds the cytoplasmic domain of some cadherins. Discover the latest research on cadherins and catenins here.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Cajal Bodies & Gems

Cajal bodies or coiled bodies are dense foci of coilin protein. Gemini of Cajal bodies, or gems, are microscopically similar to Cajal bodies. It is believed that Cajal bodies play important roles in RNA processing while gems assist the Cajal bodies. Find the latest research on Cajal bodies and gems here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Antivirals

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.